Lexaria Bioscience Corp. (LEXX)
0.9851
+0.04
(+3.78%)
USD |
NASDAQ |
Apr 22, 16:00
0.9851
0.00 (0.00%)
After-Hours: 20:00
Lexaria Bioscience Cash from Financing (TTM) : 8.207M for Feb. 28, 2026
Cash from Financing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
| Oncolytics Biotech, Inc. | 14.07M |
| Aurinia Pharmaceuticals, Inc. | -106.33M |
| Edesa Biotech, Inc. | 18.57M |
| Xenon Pharmaceuticals, Inc. | 117.36M |
| ProMIS Neurosciences, Inc. | 20.99M |